Record Information |
---|
Version | 5.0 |
---|
Status | Detected but not Quantified |
---|
Creation Date | 2021-09-11 14:22:43 UTC |
---|
Update Date | 2021-09-26 23:09:18 UTC |
---|
HMDB ID | HMDB0254898 |
---|
Secondary Accession Numbers | None |
---|
Metabolite Identification |
---|
Common Name | Mosapramine |
---|
Description | Mosapramine belongs to the class of organic compounds known as dibenzazepines. Dibenzazepines are compounds with two benzene rings connected by an azepine ring. Azepine is an unsaturated seven-member heterocycle with one nitrogen atom replacing a carbon atom. Mosapramine (Cremin) is an atypical antipsychotic used in Japan. Mosapramine is a very strong basic compound (based on its pKa). This compound has been identified in human blood as reported by (PMID: 31557052 ). Mosapramine is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically Mosapramine is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources. |
---|
Structure | OC1=NC2CCCCN2C11CCN(CCCN2C3=CC=CC=C3CCC3=C2C=C(Cl)C=C3)CC1 InChI=1S/C28H35ClN4O/c29-23-12-11-22-10-9-21-6-1-2-7-24(21)32(25(22)20-23)16-5-15-31-18-13-28(14-19-31)27(34)30-26-8-3-4-17-33(26)28/h1-2,6-7,11-12,20,26H,3-5,8-10,13-19H2,(H,30,34) |
---|
Synonyms | Value | Source |
---|
Mosapramine HCL | ChEMBL | 3-chloro-5-(3-(2-oxo-1,2,3,5,6,7,8,8a-octahydroimidazo(1,2-a)Pyridine-3-spiro-4'-piperidino)propyl)-10,11-dihydro-5H-dibenz(b,F)azepine | MeSH | Mosapramine | MeSH |
|
---|
Chemical Formula | C28H35ClN4O |
---|
Average Molecular Weight | 479.07 |
---|
Monoisotopic Molecular Weight | 478.2499395 |
---|
IUPAC Name | 1'-(3-{14-chloro-2-azatricyclo[9.4.0.0³,⁸]pentadeca-1(11),3,5,7,12,14-hexaen-2-yl}propyl)-6,7,8,8a-tetrahydro-5H-spiro[imidazo[1,2-a]pyridine-3,4'-piperidine]-2-ol |
---|
Traditional Name | 1'-(3-{14-chloro-2-azatricyclo[9.4.0.0³,⁸]pentadeca-1(11),3,5,7,12,14-hexaen-2-yl}propyl)-6,7,8,8a-tetrahydro-5H-spiro[imidazo[1,2-a]pyridine-3,4'-piperidine]-2-ol |
---|
CAS Registry Number | Not Available |
---|
SMILES | OC1=NC2CCCCN2C11CCN(CCCN2C3=CC=CC=C3CCC3=C2C=C(Cl)C=C3)CC1 |
---|
InChI Identifier | InChI=1S/C28H35ClN4O/c29-23-12-11-22-10-9-21-6-1-2-7-24(21)32(25(22)20-23)16-5-15-31-18-13-28(14-19-31)27(34)30-26-8-3-4-17-33(26)28/h1-2,6-7,11-12,20,26H,3-5,8-10,13-19H2,(H,30,34) |
---|
InChI Key | PXUIZULXJVRBPC-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as dibenzazepines. Dibenzazepines are compounds with two benzene rings connected by an azepine ring. Azepine is an unsaturated seven-member heterocycle with one nitrogen atom replacing a carbon atom. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organoheterocyclic compounds |
---|
Class | Benzazepines |
---|
Sub Class | Dibenzazepines |
---|
Direct Parent | Dibenzazepines |
---|
Alternative Parents | |
---|
Substituents | - Dibenzazepine
- Alkyldiarylamine
- Alpha-amino acid or derivatives
- Azaspirodecane
- Imidazopyridine
- Tertiary aliphatic/aromatic amine
- Azepine
- Aryl chloride
- Aryl halide
- Benzenoid
- Imidazolidinone
- Piperidine
- Imidazolidine
- Secondary carboxylic acid amide
- Carboxamide group
- Tertiary amine
- Tertiary aliphatic amine
- Lactam
- Amino acid or derivatives
- Carboxylic acid derivative
- Azacycle
- Organic nitrogen compound
- Organohalogen compound
- Organochloride
- Organonitrogen compound
- Carbonyl group
- Organooxygen compound
- Hydrocarbon derivative
- Organic oxide
- Organopnictogen compound
- Organic oxygen compound
- Amine
- Aromatic heteropolycyclic compound
|
---|
Molecular Framework | Aromatic heteropolycyclic compounds |
---|
External Descriptors | Not Available |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatized |
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Mosapramine GC-MS (Non-derivatized) - 70eV, Positive | splash10-00di-7691200000-5d479b811416e1e52d7b | 2021-09-23 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Mosapramine GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Mosapramine GC-MS (TMS_1_1) - 70eV, Positive | Not Available | 2021-11-04 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Mosapramine GC-MS (TBDMS_1_1) - 70eV, Positive | Not Available | 2021-11-04 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Mosapramine 10V, Positive-QTOF | splash10-004i-0020900000-2ea3ec63e614a6f26013 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Mosapramine 20V, Positive-QTOF | splash10-0fi3-0190400000-6819df341b880b615260 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Mosapramine 40V, Positive-QTOF | splash10-001i-9030000000-1bf956c2a055269341af | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Mosapramine 10V, Negative-QTOF | splash10-004i-0000900000-2863f2c51b9131ee012b | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Mosapramine 20V, Negative-QTOF | splash10-004i-0160900000-f41ca36af4d930fd8c6e | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Mosapramine 40V, Negative-QTOF | splash10-004l-3290100000-271695bcd0fdc0e293dd | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Mosapramine 10V, Positive-QTOF | splash10-004i-0000900000-8326517a9ce25760af0f | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Mosapramine 20V, Positive-QTOF | splash10-004i-0010900000-e32e303edc5e25abae46 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Mosapramine 40V, Positive-QTOF | splash10-0fh9-3941600000-a6e77448ecb2874d99db | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Mosapramine 10V, Negative-QTOF | splash10-004i-0010900000-f5ab68ee5c3f50b35794 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Mosapramine 20V, Negative-QTOF | splash10-004i-0000900000-eeeb00139e4eec727fa4 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Mosapramine 40V, Negative-QTOF | splash10-003r-7132900000-d7f2ba6ce0054d5045bc | 2021-10-12 | Wishart Lab | View Spectrum |
|
---|